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Using PHI-inositol-labeled human lymphocytes, formation of inositolphosphates was found as a specific response to the chemotactic formylpeptide, 
N-formyl-methionyl-leucyl-phenylalanine (fMLP), in a fashion similar to the effects of fMLP in human granulocytes. Inositol phosphate formation 
could be significantly augmented by lithium ions. The results suggest that fMLP-mediated hydrolysis of phosphoinositides is involved in its chemo- 
tactic effects on human lymphocytes. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Migration of granulocytes is mediated by a variety of 
chemotactic factors of which the chemoattractant 
oligopeptide fMLP is one of the most potent [ 1,2]. In 
spite of the large amount of information accrued on 
granulocyte chemotaxis, relatively few data are avail- 
able on lymphocyte chemotaxis, except a few reports 
about the stimulation of human lymphocyte migration 
by fMLP [3,4]. However, very little is known about ac- 
tivation of lymphocytes by fMLP and the possible bio- 
chemical mechanisms involved. 
In contrast, profound evidence indicates that fMLP- 
mediated granulocyte activation results from an inter- 
action of fMLP with a specific formylpeptide receptor 
which activates the breakdown of polyphospho- 
inositides via a G-protein coupled phospholipase C 
which finally leads to elevated cytosolic Ca2+ concen- 
trations [2,5,6]. Accordingly, we studied the possible 
presence of a similar transducing mechanism on cir- 
culating human lymphocytes by investigating the possi- 
ble effect of agonist stimulation with fMLP on the ac- 
cumulation of inositol phosphates in lymphocytes in the 
presence and the absence of lithium ions. 
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2.1. Materials 
[‘H]Inositol (spec. act. 20 Ci/mmol) was from NEN (Dreieich, 
FRG). Medium 199 and fMLP were obtained from Sigma-Chemie 
(Deisenhofen, FRG). All other chemicals used were of analytical 
grade. Incubation media were always freshly prepared and filtered 
through sterile Millex-GS 0.22 pm filter units (Millipore SA; Mol- 
sheim, France) before use. Cells were counted on a Coulter Counter 
T 540. 
2.2. Lymphocyte preparation 
Human lymphocytes were isolated from fresh blood (EDTA con- 
tainers) of healthy adult donors (aged between 23 and 35 years) using 
Ficoll-Paque (Pharmacia, Uppsala, Sweden) according to the method 
of Bojum [7] and the directions provided by the manufacturer. The 
washed lymphocytes were finally suspended in medium 199 contain- 
ing 5% autologous serum at a concentration of 10’ cells/ml. Viabili- 
ty, as determined by the Trypan blue exclusion test, was 958 or more 
and contamination with granulocytes was less than 2%. The pH of the 
incubation medium was adjusted to 7.35. 
2.3. Evaluation of inositol phosphate turnover 
For radiolabeled inositol incorporation, lymphocyte suspensions 
were incubated with [‘Hlinositol (5 &i/IO’ cells) for 24 h at 37°C in 
a shaking water bath. [‘H]Inositol-labeled cells were separated by cen- 
trifugation and resuspended in a modified Hank’s balanced salt solu- 
tion (pH 7.35) containing (in mmol/l): NaCl 124, KC1 4, Na2HP04 
0.64, KHrPO 0.66, NaHCOr 15.2, Hepes 10, MgCl2 0.2, CaClz 0.5 
and glucose 5.6. When LiCl was added, the NaCl content was cor- 
rected to achieve isotonicy. 0.18 ml of the cell suspension, about 
3 x IO6 cells, were incubated in plastic tubes with fMLP after prein- 
cubation with various concentrations of LiCl for the indicated times. 
Incubations were stopped by trichloroacetic acid 60% (final concen- 
tration 10%) and brief sonication. After centrifugation for 10 min at 
10000 x 8, the supernatants were removed and assayed for inositol 
phosphates. After removing trichloroacetic acid by diethylether ex- 
traction (four times with 0.3 ml), the supernatants were freeze dried 
and the residues dissolved in 100 pl water. The inositol phosphates 
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were separated by anion exchange chromatography [8] with some 
modifications. Briefly, 100,uI samples were applied to columns 
(15 x 0.28 cm) of Dowex 1X8-200 in the formate form. The columns 
were washed with 5 ml water and 16 ml of 5 mM sodium tetra- 
borate/60 mM sodium formate to separate labeled inositol and 
glycerophosphoinositol. IPl was eluted with 10 ml of 0.2 M am- 
monium formate/O,l M formic acid, IP2 with 12 ml of 0.6 M am- 
monium formatel0.1 M formic acid and higher inositol phosphates 
(e.g. IP3 and IP4) with 12 ml of 1.8 M ammonium formate/O.l M 
formic acid. The recovery of IPl was greater than 95% and that of 
IP2, IP3 and IP4 was about 70%, as determined with 3H-labeled 
standards. The resultant fractions were evaporated and the residues 
were dissolved in 2 ml (IPI) or 4 ml (IP2) and 8 ml (IP3 + IP4) 
water. After the addition of 16 ml Quickzint 402 (IPl) or 12 ml (IP2) 
and 24 ml (IP3 + IP4), Quickzint Flow’ 306 radioactivity was deter- 
mined on a Beckman liquid scintillation counter and transformed to 
dpm. 
3. RESULTS 
Initial experiments indicated that the incubation of 
circulating human lymphocytes with [3H]inositol leads 
to an incorporation of [3H]inositol into cell lipids, 
which is maximal after 24 h of incubation (data not 
shown). Maximal incorporation of [3H]inositol at a 
medium concentration of about 8 &i/ml was 
4 x IO4 dpm/106 cells. All further experiments were 
performed with lymphocytes incubated with t3H]in- 
ositol for 24 h. 
When lymphocytes were incubated in the presence of 
LiCl together with fMLP at a concentration of 100 nM 
which gives maximal stimulation of inositol phosphate 
accumulation in human granulocytes [2,6,9], intra- 
cellular levels of the different inositol phosphates were 
significantly elevated. The time course of the fMLP- 
stimulated increase of intracellular concentrations of 
IPr, IPz, and IP3 f IPa is given in fig. 1. Maximal levels 
of IP3 + IP4 were observed slightly before and maximal 
levels of IPz slightly after a stimulation period of 1 min, 
while maximal accumulation of IPr was only observed 
after 7-10 min of incubation (fig.1). Accumulation of 
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Fig. 1. Time course of [3H]inositol phosphate formation after stimula- 
tion with 100 nM WLP. Cells were preincubated with lithium 
chloride (10 mM) for 15 min. Baseline levels of [‘H]IPt, [.‘H]fPt and 
[3H]IP3 + [‘H]IPd were 2414, 816 and 1710 dpm/l@ lymphocytes, 
respectively. Values are means of duplicates of one representative ex- 
periment. The experiment was replicated three times. replicated three times. 
Fig.3. Effects of increasing fMLP concentration on inositol phos- 
phate accumulation. [3H]lnositoI-labeled lymphocytes were 
stimulated for 10 min with fhlLP at the concentrations indicated 
after prein~ubation with 10 mM lithium chloride. The baseline level 
of (3H]IPr was 6148 dpm/106 lymphocytes. Values are means of 
duplicates of one representative xperiment. The experiment was 
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Fig.2. Effects of increasing fMLP concentration on inositol phos- 
phate accumulation. [‘H]Inositol-labeled lymphocytes were 
stimulated for 60 s with fMLP at the concentrations indicated after 
preineubation with 10 mM lithium chloride. Values are means of 
duplicates of one representative xperiment. The experiment was 
replicated two times. 
inositol phosphates in all three fractions was strongly 
dependent on the medium concentration of fMLP (figs 
2 and 3). When stimulation was performed for 1 min, 
maximal effects were observed at fMLP concentrations 
of about 1000 nM and half-maximal effects at about 
30-50 nM for all three fractions (fig.2). When lympho- 
cytes were incubated for 10 min, fMLP was significant- 
ly more potent in stimulating IPr accumulation, with 
maximal effects seen at 100 nM and half-maximal ef- 
fects at about 5 nM (fig.3). Other neuroreceptor 
agonists including epinephrine, histamine, serotonine, 
carbachol and several other cholinergic agonists (ox- 
otremoxine, MC-A-343) were inactive in stimulating the 
accumulation of inositol phosphates in human lympho- 
cytes. 
The accumulation of inositol phosphates in all frac- 
tions was profoundly dependent on the medium con- 
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centration of LiCl when investigated at the time points 
of maximal fMLP stimulation as demonstrated in fig. 1. 
Under control conditions, i.e. without LiCl, accumula- 
tion of all three fractions ranged between 80 and 120% 
over the baseline concentrations (fig.4). However, ac- 
cumulation of all three fractions was profoundly in- 
creased by LiCl in a concentration-dependent fashion, 
with maximal effects observed at medium concentra- 
tions of about 10 mM LiCl and half-maximal effects of 
LiCl at about 0.5 mM (fig.4). Maximal effects of LiCl 
on inositol phosphate accumulation ranged from 200 to 
300% over baseline concentrations (fig. 1). 
4. DISCUSSION 
The experiments reported strongly suggest the 
presence of formylpeptide receptors on circulating 
human lymphocytes which, like similar receptors on 
human granulocytes, are linked to a phospholipase C- 
using transducing mechanism. The properties of this 
formylpeptide receptor as indicated by the time course 
of inositol phosphate stimulation, by the EDso of 
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Fig.4. Dose-response curves for lithium-induced enhancement of in- 
ositol phosphate generation. Lymphocytes were preincubated with 
the indicated lithium concentrations for 3 h, after which time uptake 
of lithium ions into lymphocytes is maximal [lo]. Cells were 
stimulated with 100 nM fMLP for 10 min in the case of IPr or for 
1 min in the case of IPa and higher inositol phosphates (IPs + IP4). 
Values are means of duplicates of one representative experiment. The 
experiment was replicated two times. 
fMLP, as well as by its maximal effective concentration 
show close similarities to the formylpeptide receptor- 
linked transducing system of human granulocytes 
[2,6,9] and strongly suggest that fMLP-mediated 
chemotaxis of human lymphocytes [3,4] might be 
mediated by mechanisms similar to those present in 
granulocytes [1,2,5,6]. Our negative findings with 
several neuroreceptor agonists confirm negative find- 
ings about the possible activation of guanylate cyclase 
in human lymphocytes with similar agents [lo]. 
However, the effects of lithium on inositol phosphate 
accumulation induced by fMLP are much more pro- 
nounced in the case of human lymphocytes than in the 
case of granulocytes, where even maximal stimulation 
only resulted in inositol phosphate levels of about 100% 
over baseline [9] or where lithium-induced amplifica- 
tion of agonist-induced inositol phosphate accumula- 
tion ranged only between 100 and 150% over baseline 
stimulation without lithium [2]. The reported effects of 
lithium on fMLP-induced accumulation of inositol 
phosphates in human lymphocytes are quite similar to 
the profound effects of lithium on the amplification of 
carbachol-, serotonine-, histamine- and phenylephrine- 
induced stimulation of inositol phosphates in slices of 
rat brain and parotid glands [4,8]. Moreover, the EDso 
observed for lithium in the present communication 
(about 0.5 mM) comes very close to its half-maximal in- 
hibitory concentration for myoinositol-L-phosphatase 
in vitro (about 0.7 mM) [12] and is even lower than its 
EDso in the two rat tissues already mentioned above 
(about 1 .O mM) [8,11]. Accordingly, fMLP-induced ac- 
cumulation of inosotol phosphates in human lympho- 
cytes represents an excellent model to study lithium ef- 
fects in man at therapeutic concentrations. 
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